Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kerstin Wirkner
Olfactory Function Is Associated With Cognitive Performance: Results From the Population-Based LIFE-Adult-Study
Alzheimer's Research and Therapy
Neurology
Cognitive Neuroscience
Nächtliche Verkehrslärmbelästigung in Deutschland: Individuelle Und Regionale Unterschiede in Der NAKO Gesundheitsstudie
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Environmental
Public Health
Occupational Health
Design Und Qualitätskontrolle Der Zahnmedizinischen Untersuchung in Der NAKO Gesundheitsstudie
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Environmental
Public Health
Occupational Health
Häufigkeit Von Asthma Bronchiale Und Alter Bei Der Erstdiagnose – Erste Ergebnisse Der NAKO Gesundheitsstudie
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Environmental
Public Health
Occupational Health
VIP Enhances Both Pre- And Postsynaptic GABAergic Transmission to Hippocampal Interneurones Leading to Increased Excitatory Synaptic Transmission to CA1 Pyramidal Cells
British Journal of Pharmacology
Pharmacology
Related publications
Neuropsychiatric Outcomes After Stroke – Authors' Reply
The Lancet Neurology
Neurology
Maximising the Value of Research for Brain Health
The Lancet Neurology
Neurology
Cannabidiol in Patients With Treatment-Resistant Epilepsy
The Lancet Neurology
Neurology
WHO Takes Up the Baton on Dementia
The Lancet Neurology
Neurology
Learning About the Brain With Comics
The Lancet Neurology
Neurology
Functional (Psychogenic) Saccadic Oscillations and Oculogyric Crises – Authors' Reply
The Lancet Neurology
Neurology
Dream Weaver
The Lancet Neurology
Neurology
The Evolution of Universally Accessible Building Design
The Lancet Neurology
Neurology
Global, Regional, and National Burden of Meningitis, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016
The Lancet Neurology
Neurology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
